DRUG · Unmapped registry intervention
Gleevec and Taxotere
Find medicine records ·
Find other trials using this name
Clinical trial
Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung Cancer
NCT00222144
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of Gleevec and Taxotere in Recurrent Non-Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
Sponsors & collaborators
University of Kansaslead sponsor
Novartiscollaborator
Kansas Masonic Cancer Research Institutecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00222144 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.